GB0819960D0 - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB0819960D0
GB0819960D0 GBGB0819960.6A GB0819960A GB0819960D0 GB 0819960 D0 GB0819960 D0 GB 0819960D0 GB 0819960 A GB0819960 A GB 0819960A GB 0819960 D0 GB0819960 D0 GB 0819960D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic composition
therapeutic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0819960.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provexis Natural Products Ltd
Original Assignee
Provexis Natural Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provexis Natural Products Ltd filed Critical Provexis Natural Products Ltd
Priority to GBGB0819960.6A priority Critical patent/GB0819960D0/en
Publication of GB0819960D0 publication Critical patent/GB0819960D0/en
Priority to PCT/GB2009/002591 priority patent/WO2010049705A2/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
GBGB0819960.6A 2008-10-31 2008-10-31 Therapeutic composition Pending GB0819960D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0819960.6A GB0819960D0 (en) 2008-10-31 2008-10-31 Therapeutic composition
PCT/GB2009/002591 WO2010049705A2 (en) 2008-10-31 2009-11-02 Therapeutic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0819960.6A GB0819960D0 (en) 2008-10-31 2008-10-31 Therapeutic composition

Publications (1)

Publication Number Publication Date
GB0819960D0 true GB0819960D0 (en) 2008-12-10

Family

ID=40138110

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0819960.6A Pending GB0819960D0 (en) 2008-10-31 2008-10-31 Therapeutic composition

Country Status (2)

Country Link
GB (1) GB0819960D0 (en)
WO (1) WO2010049705A2 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243822A (en) * 1991-01-24 1992-08-31 Tsumura & Co Calcium antagonist
JPH0585934A (en) * 1991-09-25 1993-04-06 Sumitomo Metal Ind Ltd Anti-trypsin agent
DE19720767A1 (en) * 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Use of e.g. p-hydroxybenzoic acid, gallic acid, vanillic acid, syringic acid, myricetin, quercetin and camphor oil
CN1104438C (en) * 1997-06-02 2003-04-02 山东医科大学附属医院 Mistletoe extract and its use
GB9808796D0 (en) * 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
KR100284130B1 (en) * 1998-06-03 2001-03-02 박호군 Composition for platelet aggregation inhibitor containing naringin or naringenin
IT1302863B1 (en) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa COMPOSITION WITH ANTIOXIDANT AND PREVENTIVE ACTIVITY OF THROMBOTIC AND ATHEROSCLEROTIC ALTERATIONS INCLUDING A CARNITINE AND A
US6221357B1 (en) * 1999-09-02 2001-04-24 Korea Research Institute Of Bioscience And Biotechnology Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
IT1320080B1 (en) * 2000-10-25 2003-11-18 Giuliani Spa COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE.
EP1481669A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
GB0610790D0 (en) * 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts

Also Published As

Publication number Publication date
WO2010049705A3 (en) 2010-06-24
WO2010049705A2 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
HK1253355A1 (en) Therapeutic compositions containing macitentan
EP2320907A4 (en) Therapeutic compounds
EP2268285A4 (en) Therapeutic compounds
GB0801119D0 (en) Composition
GB0810554D0 (en) Herbicde composition
EP2236149A4 (en) Medicinal composition
GB0806794D0 (en) Therapeutic compounds
GB0809808D0 (en) Composition
GB0813740D0 (en) Therapeutic compounds
GB0808835D0 (en) Therapeutic compositions
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
GB0804755D0 (en) Therapeutic compounds
EP2357204A4 (en) Composition
GB0810359D0 (en) Composition
GB0819958D0 (en) Therapeutic compositions
GB0806948D0 (en) Composition
GB0809983D0 (en) Composition
EP2490704A4 (en) Therapeutic composition
GB0804031D0 (en) Composition
GB0819960D0 (en) Therapeutic composition
GB0815700D0 (en) Therapeutic compounds
GB0811850D0 (en) Therapeutic compounds
GB0816707D0 (en) Therapeutic compounds
GB0821817D0 (en) Therapeutic compounds